Skip to main content

Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience

Graefe's Archive for Clinical and Experimental Ophthalmology volume 256, pages 2269–2270 (2018)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Blanc J, Deschasse C, Kodjikian L, Dot C, Bron AM, Creuzot-Garcher C (2018) Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-018-4016-7. Published online: May 31, 2018

    CAS  Article  Google Scholar 

  2. Călugăru D, Călugăru M (2018) Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study. Graefes Arch Clin Exp Ophthalmol 256:1209–1210

    Article  Google Scholar 

  3. Călugăru D, Călugăru M (2017) Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion. Am J Ophthalmol 176:257–258

    Article  Google Scholar 

  4. Călugăru D, Călugăru M (2017) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion. Am J Ophthalmol 184:190–191

    Article  Google Scholar 

  5. Călugăru D, Călugăru M (2017) Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal. Eur J Ophthalmol 27:e190–e191

    Article  Google Scholar 

  6. Călugăru D, Călugăru M (2015) Ranibizumab in preproliferative (ischemic) central retinal vein occlusion. The Rubeosis anti-VEGF (rave) trial. Retina 35:e59–e61

    Article  Google Scholar 

  7. Călugăru D, Călugăru M (2017) Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion. Can J Ophthalmol 52:137

    Article  Google Scholar 

  8. Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul PharmacolTher 31:78–86

    Article  Google Scholar 

  9. Călugăru D, Călugăru M (2017) Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion. Int J Ophthalmol 10:1481–1482

    PubMed  PubMed Central  Google Scholar 

  10. Călugăru D, Călugăru M (2017) Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA. Eye 31:1112–1113

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania

    Dan Călugăru & Mihai Călugăru

Authors
  1. Dan Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mihai Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors (D.C and M.C) were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Corresponding author

Correspondence to Mihai Călugăru.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Călugăru, D., Călugăru, M. Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience. Graefes Arch Clin Exp Ophthalmol 256, 2269–2270 (2018). https://doi.org/10.1007/s00417-018-4094-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-018-4094-6